130 related articles for article (PubMed ID: 31625372)
1. Human T-cell Leukemia Virus Type 2: Still Rare in Japan.
Takao M; Yoshioka N; Hagiya H; Deguchi M; Kagita M; Tsukamoto H; Hidaka Y; Tomono K; Tobe T
Clin Lab; 2019 Oct; 65(10):. PubMed ID: 31625372
[No Abstract] [Full Text] [Related]
2. Evaluation of Sensitivity and Specificity Performance of Elecsys HTLV-I/II Assay in a Multicenter Study in Europe and Japan.
Laperche S; Sauleda S; Piron M; Mühlbacher A; Schennach H; Schottstedt V; Queirós L; Uno N; Yanagihara K; Imdahl R; Hey A; Klinkicht M; Melchior W; Muench P; Watanabe T
J Clin Microbiol; 2017 Jul; 55(7):2180-2187. PubMed ID: 28468860
[TBL] [Abstract][Full Text] [Related]
3. Estimation of the window period of human T-cell leukemia virus type 1 and 2 tests by a lookback study of seroconverters among Japanese voluntary blood donors.
Sagara Y; Nakamura H; Yamamoto M; Ezaki T; Koga T; Shimamura M; Satake M; Irita K
Transfusion; 2021 Feb; 61(2):484-493. PubMed ID: 33368334
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a new third-generation ARCHITECT rHTLV-I/II assay for blood screening and diagnosis.
Kapprell HP; Stieler M; Oer M; Goller A; Hausmann M; Schochetman G; Devare SG; Qiu X
Diagn Microbiol Infect Dis; 2010 May; 67(1):61-9. PubMed ID: 20227221
[TBL] [Abstract][Full Text] [Related]
5. Detection and characterization of human T-lymphotropic viruses.
Calabrò ML; Favero A; Chieco-Bianchi L
Antibiot Chemother (1971); 1994; 46():125-33. PubMed ID: 7826033
[No Abstract] [Full Text] [Related]
6. Evaluation of a new screening assay for HTLV-1 and -2 antibodies for large-scale use.
Malm K; Kjerstadius T; Andersson S
J Med Virol; 2010 Sep; 82(9):1606-11. PubMed ID: 20648617
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy does not adversely impact diagnostic tests for HTLV-1/2 infection.
Rosadas C; Tosswill JH; Tedder R; Taylor GP
PLoS Negl Trop Dis; 2019 Sep; 13(9):e0007736. PubMed ID: 31513603
[TBL] [Abstract][Full Text] [Related]
8. Strategies for diagnosis of HTLV-I and -II.
Thorstensson R; Albert J; Andersson S
Transfusion; 2002 Jun; 42(6):780-91. PubMed ID: 12147033
[TBL] [Abstract][Full Text] [Related]
9. Development and evaluation of human T-cell leukemia virus-1 and -2 multiplex quantitative PCR.
Kuramitsu M; Okuma K; Tezuka K; Nakamura H; Sagara Y; Kurane I; Hamaguchi I
Microbiol Immunol; 2019 Nov; 63(11):458-464. PubMed ID: 31429972
[TBL] [Abstract][Full Text] [Related]
10. [Type 1 and 2 human lymphotropic virus: new perspectives].
Pardo F; Tirado MD; Sabater S; Granados J
Enferm Infecc Microbiol Clin; 2010 Oct; 28(8):568; author reply 569. PubMed ID: 20444526
[No Abstract] [Full Text] [Related]
11. A novel high performing multiplex immunoassay Multi-HTLV for serological confirmation and typing of HTLV infections.
Marqué L; Liehl P; De Boer J; Pottel H; Murphy EL; Bruhn R; Stone M; Kaidarova Z; Lee TH; Busch M; Zrein M
PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009925. PubMed ID: 34724004
[TBL] [Abstract][Full Text] [Related]
12. Droplet digital PCR for absolute quantification of proviral load of human T-cell lymphotropic virus (HTLV) types 1 and 2.
Thulin Hedberg S; Eriksson L; Demontis MA; Mölling P; Sundqvist M; Taylor G; Malm K; Andersson S
J Virol Methods; 2018 Oct; 260():70-74. PubMed ID: 30006102
[TBL] [Abstract][Full Text] [Related]
13. Loop-Mediated Isothermal Amplification (LAMP) Assay for Rapid and Accurate Confirmatory Diagnosis of HTLV-1/2 Infection.
Gomes Y; Caterino-de-Araujo A; Campos K; Gonçalves MG; Leite AC; Lima MA; Araújo A; Silva MT; Espíndola O
Viruses; 2020 Sep; 12(9):. PubMed ID: 32899621
[TBL] [Abstract][Full Text] [Related]
14. [Confirmation of the presence in Cuba of human T-cell lymphotropic virus type I using the polymerase chain reaction].
Rolo Gómez F; De Armas MB; Mato Luis J; Lubián Caballero AL; Díaz Torres H
Rev Cubana Med Trop; 1997; 49(3):204-8. PubMed ID: 9685988
[TBL] [Abstract][Full Text] [Related]
15. A new endemic focus of human T lymphotropic virus type II carriers among Orinoco natives in Colombia.
Fujiyama C; Fujiyoshi T; Miura T; Yashiki S; Matsumoto D; Zaninovic V; Blanco O; Harrington W; Byrnes JJ; Hayami M
J Infect Dis; 1993 Oct; 168(4):1075-7. PubMed ID: 8376825
[No Abstract] [Full Text] [Related]
16. HTLV-I and HTLV-II infections in volunteer blood donors and high-risk groups in Lebanon.
Naman R; Klayme S; Naboulsi M; Mokhbat J; Jradi O; Ramia S
J Infect; 2002 Jul; 45(1):29-31. PubMed ID: 12217728
[TBL] [Abstract][Full Text] [Related]
17. Detection of human T-lymphotropic virus (HTLV) tax sequences in New York City blood donors seronegative for HTLV types 1 and 2.
Dezzutti CS; Guenthner PC; Daniel S; Utz U; Cabrera T; Marshall JH; Bianco C; Lal RB; Cowan EP
Clin Diagn Lab Immunol; 2003 Jul; 10(4):715-7. PubMed ID: 12853410
[TBL] [Abstract][Full Text] [Related]
18. [HTLV-I and HTLV-II viruses: fifteen years after their description].
Delaporte E
Med Trop (Mars); 1995; 55(1):17-20. PubMed ID: 7637602
[No Abstract] [Full Text] [Related]
19. [HTLV-I and HTLV-II virus].
Maniez-Montreuil M
Ann Biol Clin (Paris); 1998; 56(5):563-70. PubMed ID: 9769480
[TBL] [Abstract][Full Text] [Related]
20. Absence of human T cell lymphotrophic virus (HTLV) type I and II DNA in French anti-HTLV-I/II-negative intravenous drug users.
Lefrère F; Wattel E; Mariotti M; Agis F; Gordien E; Lefrère JJ
J Infect Dis; 1992 Jul; 166(1):212-3. PubMed ID: 1607702
[No Abstract] [Full Text] [Related]
[Next] [New Search]
